.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
Providing miscellaneous Medtox testing supplies. Medtox Diagnostics Inc has various urine, drug screening, etc. testing supplies to be ordered on an as needed basis for an integral part to multiple triage scenarios, including mentally altered patients, and prenatal screening for patient care services testing at the facility. The contract will have a base year and four option years. The anticipated period of performance is from February 02, 2026 to February 01,2027.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
The Indian Health Service (Four Corners Regional Health Center) intends to restrict competition and negotiate a firm-fixed-price BPA with Medtox Diagnostics Inc for various urine, drug screen, and testing supplies for patient care. This posting is a Notice of Intent (Special Notice) and is not a request for quotations or proposals; however, vendors may submit capability statements to the point of contact for government consideration. The anticipated period of performance is Feb 02, 2026 to Feb 01, 2027, with a base year and four option years and NAICS 621511 (Medical Laboratories).
Posted Date
Jan 2, 2026
Due Date
Jan 19, 2026
Release: Jan 2, 2026
Close: Jan 19, 2026
The Indian Health Service (Four Corners Regional Health Center) intends to restrict competition and negotiate a firm-fixed-price BPA with Medtox Diagnostics Inc for various urine, drug screen, and testing supplies for patient care. This posting is a Notice of Intent (Special Notice) and is not a request for quotations or proposals; however, vendors may submit capability statements to the point of contact for government consideration. The anticipated period of performance is Feb 02, 2026 to Feb 01, 2027, with a base year and four option years and NAICS 621511 (Medical Laboratories).
AvailableThe Indian Health Service (Four Corners Regional Health Center) issued a Notice of Intent to negotiate a firm-fixed-price Blanket Purchase Agreement (BPA) with Medtox Diagnostics Inc for various urine and drug screening/testing supplies. The notice states Medtox is the only source reasonably available and invites vendors to submit capability statements; it is not a solicitation and no competitive solicitation will be issued unless the government elects to compete. The anticipated period of performance is Feb 02, 2026 to Feb 01, 2027 and responses are due Jan 19, 2026.
Posted Date
Jan 2, 2026
Due Date
Jan 19, 2026
Release: Jan 2, 2026
Close: Jan 19, 2026
The Indian Health Service (Four Corners Regional Health Center) issued a Notice of Intent to negotiate a firm-fixed-price Blanket Purchase Agreement (BPA) with Medtox Diagnostics Inc for various urine and drug screening/testing supplies. The notice states Medtox is the only source reasonably available and invites vendors to submit capability statements; it is not a solicitation and no competitive solicitation will be issued unless the government elects to compete. The anticipated period of performance is Feb 02, 2026 to Feb 01, 2027 and responses are due Jan 19, 2026.
Various urine, drug screening, etc. testing supplies to be ordered on an as needed basis for an integral part to multiple triage scenarios, including mentally altered patients, and prenatal screening for patient care services testing at the facility. Period of Performance shall be for a duration of one year; 02/01/2026 – 01/31/2026.
Posted Date
Jan 2, 2026
Due Date
Jan 16, 2026
Release: Jan 2, 2026
Close: Jan 16, 2026
Various urine, drug screening, etc. testing supplies to be ordered on an as needed basis for an integral part to multiple triage scenarios, including mentally altered patients, and prenatal screening for patient care services testing at the facility. Period of Performance shall be for a duration of one year; 02/01/2026 – 01/31/2026.
The Navajo Area Indian Health Service, Kayenta Health Center (KHC) intends to negotiate a non-competitive firm-fixed-price award to MedTox Diagnostics, Inc. for various urine and drug screening/testing supplies to support patient care (including mentally altered patients and prenatal screening). This notice is a Special Notice/Notice of Intent (not a solicitation or request for offers) and invites capability statements by 2026-01-16 13:00 EST to help determine whether to award non-competitively. Period of performance is listed as one year (02/01/2026 – 01/31/2026) and the government states MedTox Diagnostics, Inc. is uniquely qualified under FAR 8.405-6(a)(1)(i)(B).
Posted Date
Jan 2, 2026
Due Date
Jan 16, 2026
Release: Jan 2, 2026
Close: Jan 16, 2026
The Navajo Area Indian Health Service, Kayenta Health Center (KHC) intends to negotiate a non-competitive firm-fixed-price award to MedTox Diagnostics, Inc. for various urine and drug screening/testing supplies to support patient care (including mentally altered patients and prenatal screening). This notice is a Special Notice/Notice of Intent (not a solicitation or request for offers) and invites capability statements by 2026-01-16 13:00 EST to help determine whether to award non-competitively. Period of performance is listed as one year (02/01/2026 – 01/31/2026) and the government states MedTox Diagnostics, Inc. is uniquely qualified under FAR 8.405-6(a)(1)(i)(B).
Surface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis